Connect with us

Marijuana Stocks

BDS Analytics CEO Discusses the Current CBD Market and Importance of Data



BDS Analytics CEO Discusses the Current CBD Market and Importance of Data
- Ad -
  • Roy Bingham co-founded BDS Analytics with Liz Stahura in 2015.
  • He predicts that the global market for cannabis will reach $40 billion in the next five years.

UK native Roy Bingham is known for his work in economics, statistics, and finance, but his most notable role has been as the co-founder and CEO of BDS Analytics. Graduating from Harvard with a master’s degree in Business Administration, Bingham recently noted in an interview with Daily Camera, “I have a strong background in finance.”

Before the founding of BDS Analytics in 2015, Bingham worked with McKinsey & Co., SPINS, NourishLife, LLC, and others. He also co-founded Nutrition Business Journal and eventually found his way to Boulder, Colorado in the founding of BDS Analytics. He co-founded the company with Liz Stahura, who he met through CanopyBuilder.

Last week, Daily Camera interviewed Bingham, asking about the role that data plays to him.

He explained, “Data drives action. Data are essential building blocks to creating successful businesses and promoting growth by focusing on critical areas. It helps you separate what may be termed as less important issues in a given context.”

The interviewer also asked about the work he did as a corporate executive and his independence of being an entrepreneur.

In the discussion of these two roles, Bingham stated,

“An executive’s primary role is to improve an existing product or a company. An entrepreneur primarily creates something from scratch. Both need to understand the importance of data in growing their businesses.”

For entrepreneurs that need to raise capital of their own, Bingham advised the individuals to have a clear plan as they develop their business, and to ensure good communication of those plans.

At BDS, Bingham explained the data collection procedures, explaining,

“We track retail transactions through dispensary point-of-sale systems. We track different products, product categories and brands. We also collect consumer data through online surveys across local, national, and international markets that is updated every six months. Our expertise is in making sense of raw data and providing actionable insights to stakeholders in the space.”

The cannabinoid market is constantly changing. However, this data collected by BDS Analytics and Bingham is helpful in determining certain trends that could continue in the cannabinoid market. He stated that the 2018 Farm Bill has been helpful to the progress of the industry, as has the changes in regulatory measures.

He noted,

“The legal cannabis industry in the United States will contribute nearly $40 billion in total economic output and create a total employment effect of almost 414,000 full-time equivalent workers by 2021.”

As for CBD, he stated that this market “will increase from $2 billion in 2019 to $20 billion in 2024. Currently, dispensaries sell 65% of CBD products in the country. Their share will come down to 26% by 2024. CBD is escaping from dispensaries to general sales channels.”

Globally, the cannabis market has seen $15 billion in sales, and the US is credited to 88% of that progress. However, he sees the next five years as having substantial progress, commenting, “By 2024, the global market will be $40 billion, with the share of the U.S. coming down to 75%.”

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.